U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07076914) titled 'Prophylactic Proton Pump Inhibition for Esophageal Protection in Lung Radiation Therapy' on July 03.
Brief Summary: A randomized controlled trial to assess the impact of prophylactic proton pump inhibitor use to improve esophagitis in lung cancer patients undergoing radiation. Patients will be randomized into a standard of care arm or the prophylactic proton pump (daily) arm.
Study Start Date: Oct. 02, 2025
Study Type: INTERVENTIONAL
Condition:
Primary Lung Cancer
Non Small Cell Lung Cancer
Small Cell Lung Cancer
Intervention:
DRUG: Experimental (Health Canada Approved Proton Pump Inhibitors)
The intervention uses a proton pu...